Navigation Links
Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
Date:10/26/2009

SAN DIEGO, Oct. 26 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, presented the results of three 5-aminosalicylic acid (5-ASA) persistency analyses at ACG 2009 Annual Scientific Meeting, evaluating persistency of Lialda® (mesalamine), Asacol® (mesalamine), Pentasa® (mesalamine) (250mg and 500mg), balsalazide [combined results from generic balsalazide disodium and Colazal® (balsalazide disodium)], and Dipentum® (olsalazine sodium) (500mg). Additionally, on October 27, 2009, Shire will present results of a Lialda patient experience survey as well as the results of a study that evaluated the impact of oral 5-ASAs on all-cause health care utilization and costs among ulcerative colitis (UC) patients with active disease.

"Persistency plays a significant role in the management of UC, and this data shows us just how challenging adherence can be for UC patients," said Roger Adsett, senior vice president of Shire's GI business unit. "The results of the Lialda and 5-ASA persistency analyses will provide insights as to how UC patients manage their mesalamine prescription refills."

Lialda is an FDA-approved, once-daily oral medication for the induction of remission in patients with active, mild to moderate UC. The safety and effectiveness of Lialda beyond eight weeks have not been established.

Factors Affecting Persistence with Mesalamine Therapy: Results from a Large Pharmacy Database

Poster Presentation: October 25, 2009, San Diego Convention Center (#293)

Results of a long-term persistency analysis showed that after 18 months of treatment, 13 percent of Lialda patients (n=6,170) were persistent (continuing). Also, 5 percent of Asacol patients (n=25,887), 6 percent (250m
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
2. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
3. Veriscrip and DAMMAD Team Up to Combat Prescription Drug Abuse in New Hampshire
4. New Hampshire Rx Card Launching Statewide
5. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
6. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
7. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
8. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
9. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
10. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
11. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  An international roster of experts ... 18, in Santa Monica, Calif. , ... therapies for MPM, a rare form of cancer that ... pleura, the lining of the chest. Hosted ... Institute, the 3rd Annual International Symposium on Lung-Sparing Therapies ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/24/2013)... China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or ... in China , today announced that ... issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai ... that on May 21, 2013, Ms. Siu ... shareholders of the Company, and her spouse, Mr. Tung ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
(Date:5/24/2013)... people who hear voices help schizophrenics? Finding the answer for ... University of Bergen. , Researchers from the Bergen fMRI Group ... to help schizophrenics, who hear voices. The way they do ... who do not suffer from a mental illness. For a ... people to hear voices. A recent report published in ...
(Date:5/24/2013)... Reporter , , THURSDAY, May 23 (HealthDay News) -- Type ... with signs of serious complications seen just a few ... on the latest results, it seems like type 2 ... Chiang, senior vice president of medical affairs and community ... faster, and it appears to be at a more ...
(Date:5/24/2013)... Dallas, Texas (PRWEB) May 24, 2013 ... to 2022” provides an overview of the risk factors ... markets (8MM) (US, France, Germany, Italy, Spain, UK, Australia, ... incident cases of meningococcal disease segmented by age (<1, ... serogroup (B, C, Y, and W-135) in these markets. ...
(Date:5/24/2013)... BroadConnect Telecom, the nation’s leading ... IT security solutions, present small to midsized businesses ... more than fifty percent (when compared to conventional ... Bundle Pricing. BroadConnect’s hosted Voice solutions are putting ... , Starting today, until the end of June ...
(Date:5/24/2013)... With today’s levels of weight gain and ... on the causes of weight gain and how to lose ... causes of weight gain and treatments that will help patients ... released by the Child Study Center at NYU Langone Medical ... of ADHD and the soring rates of obesity later in ...
Breaking Medicine News(10 mins):Health News:Help at hand for schizophrenics 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:BroadConnect Is Offering New Hosted PBX Bundle Pricing for New Customers, Eliminating VoIP Adoption Barriers 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Help Patients with Weight Gain Linked to Childhood ADHD Lose Weight Fast 2
... ,Sarcopenia low skeletal muscle mass and strength is ... been hypothesized that sarcopenia puts individuals at risk for developing ... of sarcopenia on insulin resistance (the root cause of Type ... non-obese people, UCLA researchers performed a cross-sectional analysis of data ...
... rather than global, vaccines, researchers say , THURSDAY, May 27 ... United States each spring, some strains of influenza actually migrate, ... farther away, a new study suggests. , "The prevailing view ... is the out-of-tropics hypothesis, in which the strains that bring ...
... Kids Create ... ... even the best toys in the doctor’s office can’t make them feel any better. ... redirect their thoughts toward something a little sunnier. Pediatricians can now equip their offices ...
... 5 survivors risks another attack when doctors fail to ... 27 (HealthDay News) -- Despite an increased likelihood that ... medications when released from the hospital, more than 16 ... hand, a large new study reveals. , This means ...
... age threshold up from 40, to 50 for men, ... Three major medical groups have pushed upwards the recommended age ... a first heart attack or stroke. , According to a ... Association and the American College of Cardiology, only male diabetics ...
... million people in Bangladesh are exposed to unsafe levels of ... cancer and other serious diseases, according to the World Health ... is near the surface, many people in Bangladesh have installed ... arsenic. In recent years, farmers have begun using ...
Cached Medicine News:Health News:Flu May Migrate Rather Than Die Out 2Health News:Lemons to Aid Launches Pediatric Kit 2Health News:Too Many Stroke Patients Go Without Statins 2Health News:Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later 2Health News:Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later 3Health News:Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later 4Health News:Scientists offer solutions to arsenic groundwater poisoning in southern Asia 2Health News:Scientists offer solutions to arsenic groundwater poisoning in southern Asia 3Health News:Scientists offer solutions to arsenic groundwater poisoning in southern Asia 4
Inquire...
... calibration mass for convenient Touch-key ... Fully Automatic Self-Calibration at designated ... are detected, or touch-key calibration ... Interface, Shimadzu WindowsDirect communication function. ...
60 month warranty; Internal Calibration Mass System Diagnostic to alert operator of abnormal weighing conditions; built-in motorized calibration weight enabling automatic self calibration....
... unique DNA sequencing reagents including linear ... and cyanine-based infrared dyes- coupled with online ... ore meaningful raw data, and higher-quality final ... CEQ 8800 to resolve complex sequences, filling ...
Medicine Products: